WealthBridge Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,597
Closed -$220K 209
2024
Q3
$220K Buy
7,597
+50
+0.7% +$1.46K 0.06% 197
2024
Q2
$211K Sell
7,547
-1,164
-13% -$32K 0.07% 176
2024
Q1
$242K Sell
8,711
-884
-9% -$24.5K 0.08% 159
2023
Q4
$276K Sell
9,595
-870
-8% -$26.3K 0.1% 127
2023
Q3
$347K Buy
10,465
+474
+5% +$16.8K 0.14% 109
2023
Q2
$366K Sell
9,991
-7,048
-41% -$274K 0.15% 110
2023
Q1
$695K Buy
17,039
+835
+5% +$36.1K 0.28% 73
2022
Q4
$830K Sell
16,204
-114
-0.7% -$5.47K 0.35% 64
2022
Q3
$856K Hold
16,318
0.37% 57
2022
Q2
$856K Sell
16,318
-37
-0.2% -$1.89K 0.37% 57
2022
Q1
$847K Buy
16,355
+6,009
+58% +$312K 0.32% 73
2021
Q4
$611K Sell
10,346
-232
-2% -$11.5K 0.23% 87
2021
Q3
$455K Sell
10,578
-189
-2% -$8.37K 0.17% 104
2021
Q2
$422K Buy
10,767
+224
+2% +$8.71K 0.15% 105
2021
Q1
$382K Sell
10,543
-698
-6% -$24.8K 0.16% 102
2020
Q4
$414K Buy
11,241
+330
+3% +$12.1K 0.18% 95
2020
Q3
$380K Buy
10,911
+630
+6% +$22.1K 0.19% 88
2020
Q2
$319K Hold
10,281
0.18% 90
2020
Q1
$318K Buy
+10,281
New +$350K 0.22% 81
2019
Q2
Sell
-4,979
Closed -$192K 648
2019
Q1
$192K Buy
4,979
+606
+14% +$24.3K 0.12% 112
2018
Q4
$181K Buy
+4,373
New +$182K 0.14% 108

Other funds holding PFE

WealthBridge Capital Management's PFE Position: Q4 2024 in Review

WealthBridge Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,597 shares — an estimated $220K sold.

WealthBridge Capital Management first reported a position in PFE in Q4 2018 and held it in 21 quarters. The position peaked at $856K in Q3 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • WealthBridge Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • WealthBridge Capital Management sold 7,597 Pfizer shares in Q4 2024, an estimated $220K.
  • WealthBridge Capital Management first reported a position in Pfizer in Q4 2018 and held it in 21 quarters.
  • WealthBridge Capital Management's Pfizer position peaked at $856K in Q3 2022.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on WealthBridge Capital Management's 13F filing for Q4 2024, filed 3 Feb 2025.